30 trademarks were found for owners matching the name NexMed (U.S.A.), Inc..
#Classstatus
1 S:88937671
M:ACCUDOSE
O:NexMed (U.S.A.), Inc.
10 Pending
2 S:87809315
M:NEXMED
O:NexMed (U.S.A.), Inc.
5, 10 Dead
3 S:86842319
M:NEXMED (USA)
O:NexMed (U.S.A.), Inc.
5, 10 Dead
4 S:86510043
M:RAYVA
O:NexMed (U.S.A.), Inc.
5 Dead
5 S:86324391
M:ACCUDOSE
O:NexMed (U.S.A.), Inc.
10 Dead
6 S:86318069
M:MYCOVA
O:NexMed (U.S.A.), Inc.
5 Dead
7 S:86116708
M:FEMPROX

O:NexMed (U.S.A.), Inc.
5, 10 Dead
8 S:86108045
M:APRICUS BIOSCIENCES

O:NexMed (U.S.A.), Inc.
5, 42 Dead
9 S:85748643
M:BQ KITS
O:BQ KITS, INC., NexMed (U.S.A.), Inc.
10 Dead
10 S:85671702
M:THE LEADER IN SEXUAL HEALING
O:NexMed (U.S.A.), Inc.
5, 10, 42, 44 Dead
11 S:85553953
M:NEXMED
O:NexMed (U.S.A.), Inc.
5, 10 Dead
12 S:85537101
M:APRICUS PHARMA
O:NexMed (U.S.A.), Inc.
5, 10 Dead
13 S:85490886
M:NEXMED (USA)
O:NexMed (U.S.A.), Inc.
5, 10 Dead
14 S:85151573
M:NUPEN
O:NexMed (U.S.A.), Inc.
5 Dead
15 S:85129339
M:APRICUS BIO
O:NexMed (U.S.A.), Inc.
5, 10 Dead
16 S:85129419
M:APRICUS BIO

O:NexMed (U.S.A.), Inc.
5, 10 Dead
17 S:85116327
M:RAYVA
O:NexMed (U.S.A.), Inc.
5 Dead
18 S:85002932
M:PREVONCO
O:NexMed (U.S.A.), Inc.
5 Dead
19 S:85002944
M:MYCOVA
O:NexMed (U.S.A.), Inc.
5 Dead
20 S:76666974
M:VITAROS
O:ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED, NexMed (U.S.A.), Inc., WARNER CHILCOTT COMPANY, INC., WARNER CHILCOTT COMPANY, LLC
5 Dead
21 S:76552005
M:INNONYX
O:NexMed (U.S.A.), Inc.
5 Dead
22 S:76371878
M:ACCUDOSE
O:NexMed (U.S.A.), Inc.
10 Dead
23 S:75610915
M:TARGET
O:NexMed (U.S.A.), Inc.
5 Dead
24 S:75489032
M:FEMPROX
O:NexMed (U.S.A), Inc.
5 Dead
25 S:75372250
M:MEDICINES OF THE FUTURE
O:NexMed (U.S.A.), Inc.
1, 5, 10 Dead
26 S:75315419
M:NEXSTTEP
O:NexMed (U.S.A.), Inc.
5 Dead
27 S:75329597
M:NEXMED
O:NEXMED { U.S.A.}, INC, NEXMED, INC.
10 Dead
28 S:75308150
M:NEXACT
O:NEXMED (U.S.A.), INC., NexMed, Inc.
5 Dead
29 S:75153005
M:NEXMED
O:NEXMED (U.S.A.), INC., NexMed, Inc.
5 Dead
30 S:75101023
M:VIRATROL
O:NEXMED (U.S.A.), INC., NexMed, Inc.
10 Dead
Trademark Alertz updated from USPTO on 2030-01-24